169 related articles for article (PubMed ID: 9420705)
1. Heterogeneity of regional nitrogen 13-labeled ammonia tracer distribution in the normal human heart: comparison with rubidium 82 and copper 62-labeled PTSM.
Beanlands RS; Muzik O; Hutchins GD; Wolfe ER; Schwaiger M
J Nucl Cardiol; 1994; 1(3):225-35. PubMed ID: 9420705
[TBL] [Abstract][Full Text] [Related]
2. Generator-produced copper-62-PTSM as a myocardial PET perfusion tracer compared with nitrogen-13-ammonia.
Tadamura E; Tamaki N; Okazawa H; Fujibayashi Y; Kudoh T; Yonekura Y; Magata Y; Nohara R; Sasayama S; Konishi J
J Nucl Med; 1996 May; 37(5):729-35. PubMed ID: 8965135
[TBL] [Abstract][Full Text] [Related]
3. Quantification of regional myocardial perfusion with generator-produced 62Cu-PTSM and positron emission tomography.
Herrero P; Markham J; Weinheimer CJ; Anderson CJ; Welch MJ; Green MA; Bergmann SR
Circulation; 1993 Jan; 87(1):173-83. PubMed ID: 8419005
[TBL] [Abstract][Full Text] [Related]
4. Myocardial kinetics of potassium-38 in humans and comparison with copper-62-PTSM.
Melon PG; Brihaye C; Degueldre C; Guillaume M; Czichosz R; Rigo P; Kulbertus HE; Comar D
J Nucl Med; 1994 Jul; 35(7):1116-22. PubMed ID: 8014667
[TBL] [Abstract][Full Text] [Related]
5. Regional myocardial perfusion assessed with generator-produced copper-62-PTSM and PET.
Herrero P; Hartman JJ; Green MA; Anderson CJ; Welch MJ; Markham J; Bergmann SR
J Nucl Med; 1996 Aug; 37(8):1294-300. PubMed ID: 8708759
[TBL] [Abstract][Full Text] [Related]
6. Clinical application and quantitative evaluation of generator-produced copper-62-PTSM as a brain perfusion tracer for PET.
Okazawa H; Yonekura Y; Fujibayashi Y; Nishizawa S; Magata Y; Ishizu K; Tanaka F; Tsuchida T; Tamaki N; Konishi J
J Nucl Med; 1994 Dec; 35(12):1910-5. PubMed ID: 7989968
[TBL] [Abstract][Full Text] [Related]
7. The kinetics of copper-62-PTSM in the normal human heart.
Beanlands RS; Muzik O; Mintun M; Mangner T; Lee K; Petry N; Hutchins GD; Schwaiger M
J Nucl Med; 1992 May; 33(5):684-90. PubMed ID: 1569476
[TBL] [Abstract][Full Text] [Related]
8. Measurement of regional cerebral blood flow with copper-62-PTSM and a three-compartment model.
Okazawa H; Yonekura Y; Fujibayashi Y; Mukai T; Nishizawa S; Magata Y; Ishizu K; Tamaki N; Konishi J
J Nucl Med; 1996 Jul; 37(7):1089-93. PubMed ID: 8965175
[TBL] [Abstract][Full Text] [Related]
9. Human biodistribution and dosimetry of the PET perfusion agent copper-62-PTSM.
Wallhaus TR; Lacy J; Whang J; Green MA; Nickles RJ; Stone CK
J Nucl Med; 1998 Nov; 39(11):1958-64. PubMed ID: 9829589
[TBL] [Abstract][Full Text] [Related]
10. Application of the new zinc-62/copper-62 generator: an effective labeling method for 62Cu-PTSM.
Matsumoto K; Fujibayashi Y; Yonekura Y; Wada K; Takemura Y; Konishi J; Yokoyama A
Int J Rad Appl Instrum B; 1992 Jan; 19(1):39-44. PubMed ID: 1577613
[TBL] [Abstract][Full Text] [Related]
11. Cardiac emission computed tomography: underestimation of regional tracer concentrations due to wall motion abnormalities.
Parodi O; Schelbert HR; Schwaiger M; Hansen H; Selin C; Hoffman EJ
J Comput Assist Tomogr; 1984 Dec; 8(6):1083-92. PubMed ID: 6334106
[TBL] [Abstract][Full Text] [Related]
12. The Effect of Misregistration Between CT-Attenuation and PET-Emission Images in 13N-Ammonia Myocardial PET/CT.
Tomita Y; Ishida M; Ichikawa Y; Suzawa N; Kobayashi S; Maeda H; Takeda K; Sakuma H
J Nucl Med Technol; 2016 Jun; 44(2):73-7. PubMed ID: 27102660
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Cu-PTSM as a tracer of tumor perfusion: comparison with labeled microspheres in spontaneous canine neoplasms.
Mathias CJ; Green MA; Morrison WB; Knapp DW
Nucl Med Biol; 1994 Jan; 21(1):83-7. PubMed ID: 9234268
[TBL] [Abstract][Full Text] [Related]
14. Kinetics of copper-PTSM in isolated hearts: a novel tracer for measuring blood flow with positron emission tomography.
Shelton ME; Green MA; Mathias CJ; Welch MJ; Bergmann SR
J Nucl Med; 1989 Nov; 30(11):1843-7. PubMed ID: 2809749
[TBL] [Abstract][Full Text] [Related]
15. A potential copper radiopharmaceutical for imaging the heart and brain: copper-labeled pyruvaldehyde bis(N4-methylthiosemicarbazone).
Green MA
Int J Rad Appl Instrum B; 1987; 14(1):59-61. PubMed ID: 3583756
[TBL] [Abstract][Full Text] [Related]
16. 62Cu-PTSM and PET used for the assessment of angiotensin II-induced blood flow changes in patients with colorectal liver metastases.
Flower MA; Zweit J; Hall AD; Burke D; Davies MM; Dworkin MJ; Young HE; Mundy J; Ott RJ; McCready VR; Carnochan P; Allen-Mersh TG
Eur J Nucl Med; 2001 Jan; 28(1):99-103. PubMed ID: 11202458
[TBL] [Abstract][Full Text] [Related]
17. Species-dependent binding of copper(II) bis(thiosemicarbazone) radiopharmaceuticals to serum albumin.
Mathias CJ; Bergmann SR; Green MA
J Nucl Med; 1995 Aug; 36(8):1451-5. PubMed ID: 7629593
[TBL] [Abstract][Full Text] [Related]
18. Mitochondria-selective reduction of 62Cu-pyruvaldehyde bis(N4-methylthiosemicarbazone) (62Cu-PTSM) in the murine brain; a novel radiopharmaceutical for brain positron emission tomography (PET) imaging.
Fujibayashi Y; Wada K; Taniuchi H; Yonekura Y; Konishi J; Yokoyama A
Biol Pharm Bull; 1993 Feb; 16(2):146-9. PubMed ID: 8395929
[TBL] [Abstract][Full Text] [Related]
19. Performance of a 62Zn/62Cu generator in clinical trials of PET perfusion agent 62Cu-PTSM.
Haynes NG; Lacy JL; Nayak N; Martin CS; Dai D; Mathias CJ; Green MA
J Nucl Med; 2000 Feb; 41(2):309-14. PubMed ID: 10688116
[TBL] [Abstract][Full Text] [Related]
20. 13N ammonia myocardial imaging at rest and with exercise in normal volunteers. Quantification of absolute myocardial perfusion with dynamic positron emission tomography.
Krivokapich J; Smith GT; Huang SC; Hoffman EJ; Ratib O; Phelps ME; Schelbert HR
Circulation; 1989 Nov; 80(5):1328-37. PubMed ID: 2805269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
